These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 12144535)
1. Hodgkin's lymphoma in first relapse following chemotherapy or combined modality therapy: analysis of outcome and prognostic factors after conventional salvage therapy. Vassilakopoulos TP; Angelopoulou MK; Siakantaris MP; Kontopidou FN; Dimopoulou MN; Boutsis DE; Anargyrou K; Kokoris SI; Giannakakis A; Karkantaris C; Kyrtsonis MC; Tsaftaridis P; Rombos J; Variamis E; Korkolopoulou P; Kittas C; Pangalis GA Eur J Haematol; 2002 May; 68(5):289-98. PubMed ID: 12144535 [TBL] [Abstract][Full Text] [Related]
2. New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group. Josting A; Franklin J; May M; Koch P; Beykirch MK; Heinz J; Rudolph C; Diehl V; Engert A J Clin Oncol; 2002 Jan; 20(1):221-30. PubMed ID: 11773173 [TBL] [Abstract][Full Text] [Related]
3. BEACOPP and COPP/ABVD as salvage treatment after primary extended field radiation therapy of early stage Hodgkins disease - results of the German Hodgkin Study Group. Rüffer JU; Ballova V; Glossmann J; Sieber M; Franklin J; Nogova L; Diehl V; Josting A; Leuk Lymphoma; 2005 Nov; 46(11):1561-7. PubMed ID: 16236610 [TBL] [Abstract][Full Text] [Related]
4. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma. Sieniawski M; Franklin J; Nogova L; Glossmann JP; Schober T; Nisters-Backes H; Diehl V; Josting A J Clin Oncol; 2007 May; 25(15):2000-5. PubMed ID: 17420510 [TBL] [Abstract][Full Text] [Related]
5. Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy. Uematsu M; Tarbell NJ; Silver B; Coleman CN; Rosenthal DS; Shulman LN; Canellos G; Weinstein H; Mauch P Cancer; 1993 Jul; 72(1):207-12. PubMed ID: 7685241 [TBL] [Abstract][Full Text] [Related]
6. Radical radiotherapy as salvage treatment for relapse of Hodgkin's disease initially treated by chemotherapy alone: prognostic significance of the disease-free interval. Pezner RD; Lipsett JA; Vora N; Forman SJ Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):965-70. PubMed ID: 7961000 [TBL] [Abstract][Full Text] [Related]
7. Mediastinal tumor size and response to chemotherapy are the only prognostic factors in supradiaphragmatic Hodgkin's disease treated by ABVD plus radiotherapy: ten-year results of the Paris-Ouest-France 81/12 trial, including 262 patients. Colonna P; Jais JP; Desablens B; Harousseau JL; Brière J; Boasson M; Lemevel A; Casassus P; Le Prisé PY; Guilhot F; Ghandour C; Lejeune F; Andrieu JM J Clin Oncol; 1996 Jun; 14(6):1928-35. PubMed ID: 8656262 [TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle. Brice P; Bouabdallah R; Moreau P; Divine M; André M; Aoudjane M; Fleury J; Anglaret B; Baruchel A; Sensebe L; Colombat P Bone Marrow Transplant; 1997 Jul; 20(1):21-6. PubMed ID: 9232251 [TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure. Campbell B; Wirth A; Milner A; Di Iulio J; MacManus M; Ryan G Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1538-45. PubMed ID: 16125872 [TBL] [Abstract][Full Text] [Related]
10. Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy. Hodgson DC; Tsang RW; Pintilie M; Sun A; Wells W; Crump M; Gospodarowicz MK Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1374-81. PubMed ID: 14630276 [TBL] [Abstract][Full Text] [Related]
11. Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure. Longo DL; Duffey PL; Young RC; Hubbard SM; Ihde DC; Glatstein E; Phares JC; Jaffe ES; Urba WJ; DeVita VT J Clin Oncol; 1992 Feb; 10(2):210-8. PubMed ID: 1732422 [TBL] [Abstract][Full Text] [Related]
13. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma]. Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946 [TBL] [Abstract][Full Text] [Related]
14. Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy. Brusamolino E; Lazzarino M; Orlandi E; Canevari A; Morra E; Castelli G; Alessandrino EP; Pagnucco G; Astori C; Livraghi A Ann Oncol; 1994; 5 Suppl 2():101-6. PubMed ID: 7515642 [TBL] [Abstract][Full Text] [Related]
15. Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy. Shankar A; Hayward J; Kirkwood A; McCarthy K; Hewitt M; Morland B; Daw S Br J Haematol; 2014 May; 165(4):534-44. PubMed ID: 24754633 [TBL] [Abstract][Full Text] [Related]
16. A population-based study of the outcome for patients with first relapse of Hodgkin's lymphoma. Amini RM; Glimelius B; Gustavsson A; Ekman T; Erlanson M; Haapaniemi E; Enblad G Eur J Haematol; 2002 Apr; 68(4):225-32. PubMed ID: 12071938 [TBL] [Abstract][Full Text] [Related]